Chris Kilbee appointed Group Director of UBM Pharma Portfolio

Aims to expand the portfolio globally, putting increased emphasis on digital and content

Events organiser CPhI, part of UBM Live, has promoted Chris Kilbee to Group Director of the UBM Pharma Portfolio. He takes responsibility for the development of a number of events, including CPhI, ICSE, Inno-Pack and P-MEC, as well as digital solutions including CPhI Online and CPhI Pharma Evolution.

Kilbee has targeted growth in emerging markets, mirroring shifts within the wider pharma industry, with CPhI continuing to expand into the world’s largest and growing markets.

He has already overseen the launch of CPhI Istanbul – a new event starting this year – and the completion of the company’s first Annual Industry Report.

Kilbee has worked across a number of different parts of UBM, most recently running a media and events business in London, UK.

You may also like

Manufacturing

Developments in global pharmaceutical excipients in the next 3–5 years: part I

Key themes that will shape the excipient landscape in the near future will include regulations, innovation, economics and sustainability, says Dr Iain Moore, Head of Global Quality Assurance, Croda International, in this year’s <i>CPhI Annual Report</i>
Media

Trends and opportunities in biopharmaceutical product development and manufacturing

The biopharmaceutical industry and its bioprocessing sector are healthy and continue to grow in size/revenue, breadth, importance and diversity. Worldwide sales of biopharmaceuticals are now more than $300 billion, increasing at an annual rate of about 12% annually. This growth has been relatively consistent during the past 15+ years, which is why the segment is attractive to investors, explains Eric Langer, President and Managing Partner, BioPlan Associates
Media

CPhI Report predicts CGT capacity shortages in the USA and mAb approvals in China

Continuous bioprocessing is growing quickly ... but from a low base ... with virtually all manufacturers now using at least some single-use technologies
Regulatory

Former FDA commissioner to deliver talk at CPhI Festival of Pharma

Dr Scott Gottlieb will address the industry on the topic of sustainable innovation
Design & Build

CPhI Worldwide returns to Italy

The large pharma event will be hosted at the Fiera Milano in 2020, with over 47,000 professionals expected to be in attendance
Media

International investment increases in South East Asia

This increase in investment is reflected at CPhI South East Asia, taking place 27-29 March 2018 at the Jakarta International Expo (JIExpo) in Indonesia, which has seen an increase in domestic, regional and multinational manufacturers attending
Media

CPhI WW report highlights CDMO growth unpredictability in next 5 years

Flow chemistry, fermentation, repatriation of overseas funds, oncology and API/product integration to grow, but the rate of change remains unclear
Subscribe now